We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Intermittent Target Inhibition With Dasatinib 100 mg Once Daily Preserves Efficacy and Improves Tolerability in Imatinib-Resistant and -Intolerant Chronic-Phase Chronic Myeloid Leukemia
- Authors
Shah, Neil P.; Kantarjian, Hagop M.; Kim, Dong-Wook; Réa, Delphine; Dorlhiac-Llacer, Pedro E.; Milone, Jorge H.; Vela-Ojeda, Jorge; Silver, Richard T.; Khoury, H. Jean; Charbonnier, Aude; Khoroshko, Nina; Paquette, Ronald L.; Deininger, Michael; Collins, Robert H.; Otero, Irma; Hughes, Timothy; Bleickardt, Eric; Strauss, Lewis; Francis, Stephen; Hochhaus, Andreas
- Publication
Journal of Clinical Oncology, 2008, Vol 26, Issue 19, p3204
- ISSN
0732-183x
- Publication type
article
- DOI
10.1200/jco.2007.14.9260